{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"78.3"},{"groupId":"OG001","value":"72.1"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"},{"groupId":"OG001","value":"104"}],"units":"Participants"}],"description":"Total Parenteral Nutrition = yes","groups":[{"description":"Patients rinse and gargle with placebo over 1 minute QID beginning the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation.\n\nplacebo: Mouth rinse\n\nquestionnaire administration: Ancillary studies\n\nquality-of-life assessment: Ancillary studies","id":"OG000","title":"Arm I (Placebo)"},{"description":"Patients rinse and gargle with supersaturated calcium phosphate rinse over 1 minute QID beginning on the first day (about day -7) of the conditioning regimen. Treatment continues until day 20 post-transplantation.\n\nsupersaturated calcium phosphate rinse: Mouth rinse\n\nquestionnaire administration: Ancillary studies\n\nquality-of-life assessment: Ancillary studies","id":"OG001","title":"Arm II (Supersaturated Calcium Phosphate Rinse)"}],"paramType":"NUMBER","populationDescription":"Total of 210 patients evaluable for this assessment (106 Arm I \\& 104 Arm II).","reportingStatus":"POSTED","timeFrame":"Day -1 (day prior to stem cell infusion) to Day 20 following transplantation.","title":"Incidence of Total Parenteral Nutrition (TPN) Administration.","type":"SECONDARY","unitOfMeasure":"percentage of participants"}